Shandong Qidu Pharmaceutical Co. Ltd., commonly referred to as Qidu Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shandong, China. Established in 2001, the company has rapidly expanded its operations across various regions, focusing on the development and manufacturing of high-quality pharmaceutical products. Qidu Pharma specialises in a diverse range of therapeutic areas, including cardiovascular, anti-infective, and oncology medications. Their commitment to innovation is evident in their unique formulations and advanced manufacturing processes, which adhere to stringent quality standards. With a strong market presence, Qidu Pharma has achieved significant milestones, including numerous certifications and partnerships that enhance its reputation in the global pharmaceutical landscape. The company continues to strive for excellence, positioning itself as a trusted provider of effective healthcare solutions.
How does Shandong Qidu Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shandong Qidu Pharmaceutical Co. Ltd's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong Qidu Pharmaceutical Co. Ltd, headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Shandong Qidu Pharmaceutical may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Shandong Qidu to consider developing and communicating its climate strategies to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shandong Qidu Pharmaceutical Co. Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
